Cargando…
Inhibiting bladder tumor growth with a cell penetrating R11 peptide derived from the p53 C-terminus
Urothelial carcinoma of the bladder (UCB) is the most common malignancy of the urinary tract, nearly half of which contains a mutation in TP53 gene. Hence, therapeutic approach by restoring functional p53 protein in cancer cells will be beneficial. Recent studies have demonstrated the inhibition of...
Autores principales: | Zhang, Tingting, Wu, Kaijie, Ding, Chen, Sun, Kangwei, Guan, Zhenfeng, Wang, Xinyang, Hsieh, Jer-Tsong, He, Dalin, Fan, Jinhai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741965/ https://www.ncbi.nlm.nih.gov/pubmed/26462022 |
Ejemplares similares
-
Synthesis of a cell penetrating peptide modified superparamagnetic iron oxide and MRI detection of bladder cancer
por: Ding, Chen, et al.
Publicado: (2016) -
RASAL2, a RAS GTPase-activating protein, inhibits stemness and epithelial–mesenchymal transition via MAPK/SOX2 pathway in bladder cancer
por: Hui, Ke, et al.
Publicado: (2017) -
HIF-1α promotes ZEB1 expression and EMT in a human bladder cancer lung metastasis animal model
por: Zhu, Jianning, et al.
Publicado: (2018) -
HIF-1α promotes ZEB1 expression and EMT in a human bladder cancer lung metastasis animal model
por: Zhu, Jianning, et al.
Publicado: (2021) -
HAF drives the switch of HIF-1α to HIF-2α by activating the NF-κB pathway, leading to malignant behavior of T24 bladder cancer cells
por: GUAN, ZHENFENG, et al.
Publicado: (2013)